Technology | June 16, 2009

MILabs Wins Two Contracts for Low-Dose SPECT/CT



June 16, 2009 – MILabs introduced at the Annual SNM meeting its novel U-SPECT/CT system, a Micro-SPECT system that is fully integrated with the MILabs high-throughput, low dose U-CT. The company also announced it has already contracted to install two U-SPECT/CT systems. Delft University of Technology will upgrade their U-SPECT-II system to a U-SPECT/CT this summer. The University Medical Centre St. Radboud in Nijmegen, The Netherlands, has ordered to expand their small animal imaging facilities with U-SPECT/CT. The system will be used to perform research on new radiopharmaceuticals for both diagnostic and therapeutic applications. For this research objective extremely low-dose studies will be performed with U-SPECT/CT. Professor Otto Boerman, University Medical Centre St. Radboud said, "The new system provides very detailed molecular images, that will allow us to monitor fast tracer dynamics in sub-compartments of the tiny organs or tumors in a mouse or rat but also shows detailed tracer dynamics in the entire body." According to MILabs, the integrated CT makes it possible to look at a wide range of isotopes and combinations of isotopes at the sub-half-mm resolution level and localize the tracers with the same accuracy in the anatomical framework provided by the fully integrated X-ray CT. For more information:

Related Content

Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Cardiac MRI being performed at the DeBakey Heart Hospital.

Cardiac MRI being performed at the DeBakey Heart Hospital.

Feature | Cardiac Imaging | May 03, 2018 | By Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
GE Healthcare SPECT/CT and PET/CT Systems Enhance Personalized Patient Care
News | Nuclear Imaging | June 10, 2017
GE Healthcare showcased positron emission tomography (PET) and single photon emission computed tomography/computed...
advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...